April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Fluorescence lifetime imaging in a mouse model of experimental vein occlusion
Author Affiliations & Notes
  • Martin Sebastian Zinkernagel
    Dept of Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Chantal Dysli
    Dept of Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Cavit Agca
    Dept of Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Volker Enzmann
    Dept of Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Sebastian Wolf
    Dept of Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Andreas Ebneter
    Dept of Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Footnotes
    Commercial Relationships Martin Zinkernagel, Heidelberg Engineering (F); Chantal Dysli, Heidelberg Engineering (F); Cavit Agca, None; Volker Enzmann, None; Sebastian Wolf, Heidelberg Engineering (C), Heidelberg Engineering (F); Andreas Ebneter, Heidelberg Engineering (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2093. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Martin Sebastian Zinkernagel, Chantal Dysli, Cavit Agca, Volker Enzmann, Sebastian Wolf, Andreas Ebneter; Fluorescence lifetime imaging in a mouse model of experimental vein occlusion. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2093.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Fluorescent lifetime imaging ophthalmoscopy (FLIO) is a new imaging method that allows measurements of fluorescence lifetimes in vivo in the retina. In contrast to fundus autofluorescence where fluorescence intensities are measured, FLIO measures the decay time of natural fluorophores which is in the range of picoseconds (ps). We have recently established a mouse model of experimental vein occlusion. We describe here the fluorescence lifetime features in experimental vein occlusion.

 
Methods
 

Retinal vein occlusion was induced in 7 BALB/c mice in the superior vein using indirect la-ser photocoagulation. The retina was imaged at day 3 with the fluorescence lifetime imaging oph-thalmoscope. In addition fluorescein angiograms, color fundus photographs and optical coherence tomograms were obtained to verify the success of retinal vein occlusion.

 
Results
 

Fluorescence lifetime imaging was feasible in all mice and showed characteristic and highly reproducible changes in the area affected by retinal vein occlusion at day 3. Average fluorescence lifetimes in the retinal areas affected by experimental vein occlusion were significantly (831ps versus 1014ps, p<0.005) shorter when compared to healthy retina. Fluorescence lifetime analysis of the area of laser treatment was not significantly different from healthy retina (1026ps versus 1014ps).

 
Conclusions
 

We were able to show that fluorescence lifetimes are altered in the retina after experimental vein occlusion. The combination of the clinically highly relevant vein occlusion model and the fluorescence lifetime imaging technique may help to develop a better understanding of this disease and may be useful for drug development.

 
 
Autofluorescence intensity image (left) and color coded autofluorescence lifetime image (rigth). The square marks the area of the laserburn. The drainage area of the lasered vein is evident by shorter (red) autofluorescence lifetimes.
 
Autofluorescence intensity image (left) and color coded autofluorescence lifetime image (rigth). The square marks the area of the laserburn. The drainage area of the lasered vein is evident by shorter (red) autofluorescence lifetimes.
 
Keywords: 551 imaging/image analysis: non-clinical • 688 retina • 749 vascular occlusion/vascular occlusive disease  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×